Navigation Links
Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
Date:5/13/2008

WEINHEIM, Germany, May 13 /PRNewswire/ -- Caviar has become one of the rarest and most valuable delicacies. However in view of the over fished sturgeon populations in the wild, the huge demand can only be satisfied with sustainable aquaculture. United Food Technologies AG (UFT) has many years of experience and a significant advantage in know-how in this sector. This week, the company delivered a turnkey aquaculture plant to an operator in Germany. Further projects are currently being implemented on other continents.

The operators of the newly launched aquaculture plant in Jessen, Germany commissioned UFT with the complete planning, development and implementation. Following several months of construction, the plant - already scheduled to produce its first caviar this year - was launched in the presence of more than 250 guests from the economic and political sectors. About 30 000 sturgeons (Acipenser Baerii = Siberian sturgeon) were previously bred specifically for the plant on behalf of UFT and transported to Jessen by costly live transport.

United Food Technologies AG has many years of experience in aquaculture technology and is active on a worldwide scale. The patented UFT technology is highly profitable. UFT CEO Christoph Hartung emphasizes: "High profitability of the plant, protection of resources, sustainability and quality of the product are harmonized using our unique technology." Over fishing of the populations in the wild has made sturgeon and caviar a rarity. More and more commercial enterprises, caterers, hotels and airlines rely on good quality produce from aquacultures. Concerning the marketing of the plant's products, UFT offers operators and investors innovative and complete solutions, right up to bringing the products onto the market. For instance, the company entered into a partnership with Petrossian, one of the oldest and most renowned caviar trading houses worldwide.
For more information please visit http://www.uftag.de

Press contact:

Oliver Schonfeld,

Schonfeld PR,

Concept - Text - Media work,

Eschkamp 4,

48301 Nottuln,

Phone: +49(0)2509-993361,

Fax: +49(0)2509-9934302,

Mobile: +49(0)170-3284569,

E-mail: os@schoenfeld-pr.de .


'/>"/>
SOURCE United Food Technologies AG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
4. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
5. Biomira Announces Plan to Reincorporate in the United States
6. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
7. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
8. United BioSource Acquires Caro Research, Leader in Simulation Modeling
9. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
10. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
11. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):